Florida Senate - 2008 SENATOR AMENDMENT

Bill No. CS for SB 1854

549022

CHAMBER ACTION

Senate

Floor: WD/2R

4/9/2008 2:12 PM

.

.

.

.

.

House



1

Senator Wilson moved the following amendment:

2

3

     Senate Amendment (with title amendment)

4

     Between line(s) 1219 and 1220,

5

insert:

6

     Section 10.  Paragraph (p) of subsection (3) of section

7

409.91211, Florida Statutes, as amended by chapter 2007-331, Laws

8

of Florida, is amended to read:

9

     409.91211  Medicaid managed care pilot program.--

10

     (3)  The agency shall have the following powers, duties, and

11

responsibilities with respect to the pilot program:

12

     (p)  To implement standards for plan compliance, including,

13

but not limited to, standards for quality assurance and

14

performance improvement, standards for peer or professional

15

reviews, grievance policies, and policies for maintaining program

16

integrity. The agency shall develop a data-reporting system, seek

17

input from managed care plans in order to establish requirements

18

for patient-encounter reporting, and ensure that the data

19

reported is accurate and complete.

20

     1.  In performing the duties required under this section,

21

the agency shall work with managed care plans to establish a

22

uniform system to measure and monitor outcomes for a recipient of

23

Medicaid services.

24

     2.  The system shall use financial, clinical, and other

25

criteria based on pharmacy, medical services, and other data that

26

is related to the provision of Medicaid services, including, but

27

not limited to:

28

     a.  The Health Plan Employer Data and Information Set

29

(HEDIS) or measures that are similar to HEDIS.

30

     b.  Member satisfaction.

31

     c.  Provider satisfaction.

32

     d.  Report cards on plan performance and best practices.

33

     e.  Compliance with the requirements for prompt payment of

34

claims under ss. 627.613, 641.3155, and 641.513.

35

     f.  Utilization and quality data for the purpose of ensuring

36

access to medically necessary services, including

37

underutilization or inappropriate denial of services.

38

     3.  The agency shall require the managed care plans that

39

have contracted with the agency to establish a quality assurance

40

system that incorporates the provisions of s. 409.912(27) and any

41

standards, rules, and guidelines developed by the agency.

42

     4.  The agency shall establish an encounter database in

43

order to compile data on health services rendered by health care

44

practitioners who provide services to patients enrolled in

45

managed care plans in the demonstration sites. The encounter

46

database shall:

47

     a.  Collect the following for each type of patient encounter

48

with a health care practitioner or facility, including:

49

     (I)  The demographic characteristics of the patient.

50

     (II)  The principal, secondary, and tertiary diagnosis.

51

     (III)  The procedure performed.

52

     (IV)  The date and location where the procedure was

53

performed.

54

     (V)  The payment for the procedure, if any.

55

     (VI)  If applicable, the health care practitioner's

56

universal identification number.

57

     (VII)  If the health care practitioner rendering the service

58

is a dependent practitioner, the modifiers appropriate to

59

indicate that the service was delivered by the dependent

60

practitioner.

61

     b.  Collect appropriate information relating to prescription

62

drugs for each type of patient encounter, including, but not

63

limited to:

64

     (I) Data showing the unduplicated number of recipients

65

whose prescription coverage, by therapeutic class, was rejected

66

each month at the point of service because the drug was not on

67

the plan's preferred drug list, and, of those rejections:

68

     (A) The number of recipients receiving the original

69

prescription;

70

     (B) The number of recipients receiving a therapeutic brand

71

alternative;

72

     (C) The number of recipients receiving a therapeutic

73

generic alternative; and

74

     (D) The number of recipients who did not receive a

75

medication in this therapeutic class.

76

     (II) The number of recipients whose prescription coverage

77

was rejected each month due to:

78

     (A) The recipient reaching the plan cap on the number of

79

covered prescriptions; or

80

     (B) The recipient reaching the dollar cap on the cost of

81

covered prescriptions.

82

     c.  Collect appropriate information related to health care

83

costs and utilization from managed care plans participating in

84

the demonstration sites.

85

     5.  To the extent practicable, when collecting the data the

86

agency shall use a standardized claim form or electronic transfer

87

system that is used by health care practitioners, facilities, and

88

payors.

89

     6.  Health care practitioners and facilities in the

90

demonstration sites shall electronically submit, and managed care

91

plans participating in the demonstration sites shall

92

electronically receive, information concerning claims payments

93

and any other information reasonably related to the encounter

94

database using a standard format as required by the agency.

95

     7.  The agency shall establish reasonable deadlines for

96

phasing in the electronic transmittal of full encounter data.

97

     8.  The system must ensure that the data reported is

98

accurate and complete.

99

100

================ T I T L E  A M E N D M E N T ================

101

And the title is amended as follows:

102

     On line(s) 42, after the first semicolon,

103

insert:

104

amending s. 409.91211, F.S; specifying the appropriate

105

information to be collected by the encounter database

106

which relates to prescription drugs for each type of

107

patient encounter;

4/9/2008  7:50:00 AM     33-07036-08

CODING: Words stricken are deletions; words underlined are additions.